5205-82-3|Bevonium methylsulfate|2-((2-hydroxy-2,2-diphenylacetoxy)methyl)-1,1-dimethylpiperidin-1-ium methyl sulfate.|-范德生物科技公司

Bevonium methylsulfate

NMR下载 COA and HPLC MSDS下载
names：
2-((2-hydroxy-2,2-diphenylacetoxy)methyl)-1,1-dimethylpiperidin-1-ium methyl sulfate.
CAS号：
5205-82-3
MDL Number：
MF(分子式)： C23H31NO7S MW(分子量)： 465.56
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)
HCR223091-5mg	5mg	98%	¥ 1862.00	¥ 1862.00		4-7周	- +	¥ 0.00

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Bevonium methylsulfate
英文别名	CG201; CG 201; CG-201; Bevonium methylsulfate; Acabel; Piribenzil methosulfate; Piribenzil methyl sulfate; Bevonium metilsulfate.
CAS号	5205-82-3
Inchi	InChI=1S/C22H28NO3.CH4O4S/c1-23(2)16-10-9-15-20(23)17-26-21(24)22(25,18-11-5-3-6-12-18)19-13-7-4-8-14-19;1-5-6(2,3)4/h3-8,11-14,20,25H,9-10,15-17H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1
InchiKey	AXKJGGRSAVLXTE-UHFFFAOYSA-M
分子式 Formula	C23H31NO7S
分子量 Molecular Weight	465.56
溶解度Solubility	Methanol (Slightly), Water (Slightly)
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Bevonium methylsulfate(CAS:5205-82-3 ):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Bevonium methylsulfate, also known as CG201, is an antimuscarinic agent.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Stall L, Lee J, McCullough M, Nsrouli-Maktabi H, Spies JB. Effectiveness of elective unilateral uterine artery embolization: a case-control study. J Vasc Interv Radiol. 2011 May;22(5):716-22. PubMed PMID: 21514525.

[2]Hu NN, Kaw D, McCullough MF, Nsouli-Maktabi H, Spies JB. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J Vasc Interv Radiol. 2011 May;22(5):710-715.e1. PubMed PMID: 21514524.

[3] Costantino M, Lee J, McCullough M, Nsouli-Maktabi H, Spies JB. Bilateral versus unilateral femoral access for uterine artery embolization: results of a randomized comparative trial. J Vasc Interv Radiol. 2010 Jun;21(6):829-35; quiz 835. Epub 2010 Apr 15. Erratum in: J Vasc Interv Radiol. 2010 Nov;21(11):1786. Nsrouli-Maktabi, Hala [corrected to Nsouli-Maktabi, Hala]. PubMed PMID: 20399113.

[4] Banovac F, Cheng P, Campos-Nanez E, Kallakury B, Popa T, Wilson E, Abeledo H, Cleary K. Radiofrequency ablation of lung tumors in swine assisted by a navigation device with preprocedural volumetric planning. J Vasc Interv Radiol. 2010 Jan;21(1):122-9. Epub 2009 Nov 25. PubMed PMID: 19939704; PubMed Central PMCID: PMC2818540.

[5] Meyer J, Nsouli-Maktabi H, Spies JB. Quality of interventional radiology literature: a review of articles published in JVIR and CVIR. J Vasc Interv Radiol. 2009 Oct;20(10):1271-6. Epub 2009 Jul 23. Review. PubMed PMID: 19631559.

6: White AM, Banovac F, Yousefi S, Slack RS, Spies JB. Uterine fibroid embolization: the utility of aortography in detecting ovarian artery collateral supply. Radiology. 2007 Jul;244(1):291-8. PubMed PMID: 17581907.7: White AM, Banovac F, Spies JB. Patient radiation exposure during uterine fibroid embolization and the dose attributable to aortography. J Vasc Interv Radiol. 2007 Apr;18(4):573-6. PubMed PMID: 17446550.8: Spies JB, Cornell C, Worthington-Kirsch R, Lipman JC, Benenati JF. Long-term outcome from uterine fibroid embolization with tris-acryl gelatin microspheres: results of a multicenter study. J Vasc Interv Radiol. 2007 Feb;18(2):203-7. PubMed PMID: 17327552.9: Yousefi S, Czeyda-Pommersheim F, White AM, Banovac F, Hahn WY, Spies JB. Repeat uterine artery embolization: indications and technical findings. J Vasc Interv Radiol. 2006 Dec;17(12):1923-9. PubMed PMID: 17185687.10: Spies JB. Adding to our understanding of uterine fibroid embolization. AJR Am J Roentgenol. 2006 Mar;186(3):846-7. PubMed PMID: 16498119.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开